The new Hyalmass Aqua-Exosome by Maypharm combines hyaluronic acid, exosomes, and PDRN to enhance skin hydration, elasticity, and regeneration.

Maypharm unveils Hyalmass Aqua-Exosome, an innovative hybrid filler that redefines skin hydration and restoration using exosomes and PDRN.

Maypharm Co, Ltd introduces Hyalmass Aqua-Exosome, a revolutionary hybrid filler that promises enhanced skin hydration and regeneration through innovative technology.

Discover Maypharm's innovative Hyalmass Aqua-Exosome, a game-changing hybrid filler that enhances skin hydration, elasticity, and regeneration.

Maypharm introduces Hyalmass Aqua-Exosome, a groundbreaking hybrid filler that enhances skin hydration and rejuvenation with advanced technology.

Présentation de l'acide hyaluronique, des exosomes et du PDRN SÉOUL, Corée du Sud, 30 décembre 2024 /PRNewswire/ -- Maypharm Co, Ltd, l'un des principaux innovateurs en matière de produits médicaux et dermo-cosmétiques, introduit avec fierté Hyalmass…

- Maypharm presenta Hyalmass Aqua-Exosome, un revolucionario relleno híbrido: el futuro de la hidratación y regeneración de la piel Introducción al ácido hialurónico, los exosomas y el PDRN SEÚL, Corea del Sur, 30 de diciembre de 2024 /PRNewswire/ --…

Neuartige Kombination aus Hyaluronsäure, Exosomen und PDRN SEOUL, Südkorea, 30. Dezember 2024 /PRNewswire/ -- Maypharm Co., Ltd, ein führender Innovator im Bereich medizinischer und hautkosmetischer Produkte, kündigt mit Stolz die weltweite…

Introducing Hyaluronic Acid, Exosomes, and PDRN SEOUL, South Korea, Dec. 30, 2024 /PRNewswire/ -- Maypharm Co., Ltd., a leading innovator in medical and dermo-cosmetic products, proudly introduces the global launch of Hyalmass Aqua-Exosome, a…

Introducing Hyaluronic Acid, Exosomes, and PDRN SEOUL, South Korea, Dec. 30, 2024 /PRNewswire/ -- Maypharm Co., Ltd., a leading innovator in medical and dermo-cosmetic products, proudly introduces the global launch of Hyalmass Aqua-Exosome, a…